Stay Updated with Glucox Biotech Innovations

Diabetic retinopathy (DR), a leading cause of blindness among working-age individuals worldwide,...

Abstract NADPH oxidases (NOX) are activated in ischemic conditions leading to increases in reactive...

Glucox Biotech (GB) has entered into a new exciting phase by adding strong scientific and business...

The Eurostar supported project ”Neuroprotective therapy for ischemic stroke” a collaboration between...

Glucox Biotech has success in Eurostars grant application and receives financing for compound development...

Glucox Biotech has signed an agreement with Prof. Harald Schmidt of Maastricht University for further...

Glucox Biotech has signed an agreement with Accelera Srl, Milano, Italy. Accelera will evaluate pharmacokinetics...

Uppsala University and SLU have together with the European Regional Development Fund alloted Glucox...

Glucox Biotech has signed an agreement with Prof. Anders Arner of Karolinska Institutet for further...